ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

olezarsen

Also written as “Olezarsen”, “Cyclosporine Capsules USP (Modified) 100 mg” and “ISIS 678354”.

Its studies are mostly in Hypertriglyceridemia, led by 2 companies.

Drug pageOlezarsen: every studyAll 13 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since Sep 23, 202013 company-led studies, 4 open or runningNext primary completion: Mar 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Ionis Pharmaceuticalsits history only114 open or runningphase 3since Sep 23, 2020Dec 1, 2017Mar 2027phase 3 · NCT05681351
Panacea Biotec20 open or runningno phasesince Mar 2, 2010Mar 2, 2010none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Panacea Biotec only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). An open circle marks the day WHO proposed its name. Dates ahead are the sponsors’ estimates.

  1. Mar 2, 2010First studies: 2 no phase studies in Healthy VolunteersFirst studyNCT01080586, NCT01080560
  2. Jul 28, 2021Named olezarsenINNProposed as its International Nonproprietary Name in WHO's List 125 · before, ISIS 678354

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 Panacea Biotec leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT01080586Healthy Volunteers · India–CompletedSep 200736
NCT01080560Healthy Volunteers · India–CompletedSep 200736

How it is read

Names in the registry

  • “Olezarsen”, 10 entries
  • “Cyclosporine Capsules USP (Modified) 100 mg”, 2 entries
  • “ISIS 678354”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.